PHC

LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with Its Interoperable Precision Health Solutions

Retrieved on: 
Monday, May 16, 2022 - 3:00pm
Cloud, Achievement, Interoperability, Leadership, Patient, Frost & Sullivan, Solution, Big data, Health, PHC, Technology, Frost, SAN, Industry, Super Mario, Awareness, Health education, Machine learning, Adoption, Software as a service, Diagnosis, HCPS, Medicine, Medical device

SAN ANTONIO, May 16, 2022 /PRNewswire/ -- Based on a recent industry assessment of the precision health informatics market, Frost & Sullivan recognizes LifeOmic with the 2021 North America Enabling Technology Leadership Award. The company provides a precision health-specific healthcare system and governance to improve access and awareness, thus driving adoption. It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals. These solutions include disease management and treatment, patient monitoring, corporate wellness, individual wellness, and health education.

Key Points: 
  • SAN ANTONIO, May 16, 2022 /PRNewswire/ -- Based on a recent industry assessment of the precision health informatics market, Frost & Sullivan recognizes LifeOmic with the 2021 North America Enabling Technology Leadership Award.
  • It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals.
  • LifeOmic's Interoperable Precision Health solutions with advanced analytics collect holistic information from the underlying sources across the care continuum and normalize evidence at the patient, provider, and payer levels.
  • The Precision Health Cloud (PHC), the foundational cloud platform, includes solutions for precision oncology, medical research, remote patient monitoring, patient-reported outcomes, and cardiovascular treatments.

LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with Its Interoperable Precision Health Solutions

Retrieved on: 
Monday, May 16, 2022 - 3:00pm
Cloud, Achievement, Interoperability, Leadership, Patient, Frost & Sullivan, Solution, Big data, Health, PHC, Technology, Frost, SAN, Industry, Super Mario, Awareness, Health education, Machine learning, Adoption, Software as a service, Diagnosis, HCPS, Medicine, Medical device

SAN ANTONIO, May 16, 2022 /PRNewswire/ -- Based on a recent industry assessment of the precision health informatics market, Frost & Sullivan recognizes LifeOmic with the 2021 North America Enabling Technology Leadership Award. The company provides a precision health-specific healthcare system and governance to improve access and awareness, thus driving adoption. It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals. These solutions include disease management and treatment, patient monitoring, corporate wellness, individual wellness, and health education.

Key Points: 
  • SAN ANTONIO, May 16, 2022 /PRNewswire/ -- Based on a recent industry assessment of the precision health informatics market, Frost & Sullivan recognizes LifeOmic with the 2021 North America Enabling Technology Leadership Award.
  • It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals.
  • LifeOmic's Interoperable Precision Health solutions with advanced analytics collect holistic information from the underlying sources across the care continuum and normalize evidence at the patient, provider, and payer levels.
  • The Precision Health Cloud (PHC), the foundational cloud platform, includes solutions for precision oncology, medical research, remote patient monitoring, patient-reported outcomes, and cardiovascular treatments.

DGAP-News: Results for the year ended 31 December 2021

Retrieved on: 
Saturday, May 14, 2022 - 12:02am
Knowledge, EPA, Nutrien, Company, Plant, Coffee, Livestock, Rust (programming language), EMEAA, Environment, Richard Harpin, Food, Farmer, PHC, Wilbur-Ellis Co. v. Kuther, Partnership, Soybean, Phakopsora pachyrhizi, Technology, Citrus, Fruit, Agave, Group, Protein, Growth, Vegetable, Agrianes, Agriculture, Vegetable oil, Fine chemical, Agriculture

Sales in USA corn were up 133% in 2021, driven by strong demand for the Group's Harpin seed treatment product.

Key Points: 
  • Sales in USA corn were up 133% in 2021, driven by strong demand for the Group's Harpin seed treatment product.
  • Sales of Harpin for PHC in Brazil sugarcane grew 108% even under challenging drought conditions in 2021.
  • Sugar cane growers experienced extreme drought during the 2021 growing season which reduced yield by more than 13%.
  • 2021 sales in the EMEAA region were up 31% with growth in Spain and the UK.

PHC Holdings Corporation Appoints Shoji Miyazaki as Chief Executive Officer

Retrieved on: 
Thursday, April 28, 2022 - 11:02am
Medical Devices, Health, Technology, Diabetes, Hospitals, Other Technology, PHC, Leg, CEO, Director, IPO, Mass meeting, Patient, JPY, Efficiency, COO, Electronics, Diabetes, Board, Mitsui & Co., Satō, Mitsui, Health, Panasonic, Management, Pharmaceutical industry, EU

PHC Holdings Corporation (hereafter PHC Group) (TOKYO:6523) today announced the appointment of Shoji Miyazaki as the companys Chief Executive Officer.

Key Points: 
  • PHC Holdings Corporation (hereafter PHC Group) (TOKYO:6523) today announced the appointment of Shoji Miyazaki as the companys Chief Executive Officer.
  • Shoji Miyazaki was previously PHC Group's Chief Operating Officer and former President of PHC Corporation and brings more than 30 years of experience at PHC Group and Panasonic.
  • Sato joins PHC Group from his current role as Chief Executive Officer in the Hong Kong Branch of MBK Healthcare Management Pte.
  • Its subsidiaries include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia, and LSI Medience Corporation.

KKR Announces Tender Offer to Acquire Hitachi Transport System

Retrieved on: 
Thursday, April 28, 2022 - 7:10am
Finance, Consulting, Logistics, Supply Chain Management, Professional Services, Transport, PHC, ESG, Life, NYSE, CEO, Sale, Share repurchase, Magneti Marelli, KKR, Twitter, Investment, TSE, HTS, Technology, Efficiency, Growth, Company, Mitsubishi, Voice acting in Japan, Transport, Biophysical environment, Retirement, Insurance, Software as a service, Security (finance), Cryptocurrency, Financial services, Social, Offer and acceptance

In connection with the tender offer, the Offeror has entered into an agreement (the Agreement) with Hitachi, Ltd. (Hitachi), the lead shareholder of HTS, under the terms of which, following a share consolidation after the tender offer, HTS will acquire Hitachis 39.91% holding in a share buyback.

Key Points: 
  • In connection with the tender offer, the Offeror has entered into an agreement (the Agreement) with Hitachi, Ltd. (Hitachi), the lead shareholder of HTS, under the terms of which, following a share consolidation after the tender offer, HTS will acquire Hitachis 39.91% holding in a share buyback.
  • The proposed tender offer price represents1:
    A premium of 166.22% to Hitachi Transport Systems 12-month average closing price to June 16, 2021
    A premium of 161.53% to Hitachi Transport Systems 6-month average closing price to June 16, 2021
    KKR expects to commence the tender offer by late September 2022, subject to regulatory approvals in Japan and other jurisdictions.
  • For details regarding the conditions of the commencement of the tender offer, please refer to the full text of the filing notice issued today titled, Notice regarding the commencement of the tender offer for Hitachi Transport System Ltd. (TSE stock code 9086).
  • If shareholders wish to make an offer to sell their shares in the tender offer, they should first read the tender offer explanation statement for the tender offer and offer their shares or stock options for sale at their own discretion.

PHC Receives First EU-MDR Certification, Delivers Motorized Drug Injection Device Enabling More Efficient Patient-Friendly Treatment of Arthritis and Other Inflammatory Conditions

Retrieved on: 
Monday, April 18, 2022 - 6:00am
Pharmaceutical, Other Manufacturing, Hardware, Health, Medical Devices, Technology, Manufacturing, Mobile, Wireless, AIMD, Board, Medical Devices Directive, MDD, Medical Device Regulation Act, TNF, European Commission, Asthma, TOKYO, Diagnosis, Classification, Patient, Patient safety, PHC, IVD, Mark (given name), Royal commission, Smartphone, Rheumatoid arthritis, Digital technology, Solution, LCD, IIA, Safety, Medical device, Public health, Diabetes, Certification, Name, Health, EU

The device, called APP-1000*1, is designed to provide simple, precise, and monitored drug injections in the home setting for conditions including rheumatoid arthritis.

Key Points: 
  • The device, called APP-1000*1, is designed to provide simple, precise, and monitored drug injections in the home setting for conditions including rheumatoid arthritis.
  • APP-1000 is a class IIa*2 portable medical device, manufactured at PHC IVDs Wakimachi plant in Japan.
  • It allows patients to self-inject TNF inhibitors automatically at a touch of a button with no measurement or preparation required.
  • The device comes equipped with an LCD screen with illustrated guidance to make it easier for patients to use.

9am.health Further Expands Virtual Diabetes Clinic by Partnering With Ascensia to Add the CONTOUR®NEXT ONE Blood Glucose Meter to Its Patient Toolkit

Retrieved on: 
Wednesday, March 23, 2022 - 11:30am
Marketing, Pharmacy, Blood, Multimedia, CONTOUR, Prediabetes, Patient, Prescription, Nutritionist, Pharmacist, Entrepreneurship, PMID, Type 2 diabetes, Technology, Acquisition, Contour, Diabetes, Founders Fund, PHC, Time, SAN, Category:Scientific & Academic Publishing academic journals, Insurance, Glucose, Medical device, Pharmaceutical industry

SAN DIEGO, March 23, 2022 /PRNewswire/ -- 9am.health announces that it now offers the CONTOUR®NEXT ONE blood glucose meter and CONTOUR® NEXT test strips to its patients with type 2 diabetes and prediabetes to complement its all-in-one virtual diabetes care offering.

Key Points: 
  • Our remarkably accurate1 CONTOURNEXT ONE glucose meter is a great addition to their virtual diabetes clinic.
  • Patients can now add a free CONTOURNEXT ONE blood glucose meter and 100- 300 test strips to their 9am.health personalized treatment plan.
  • For further information, please visit the Ascensia Diabetes Care website at: http://www.ascensia.com
    2022 Ascensia Diabetes Care Holdings AG.
  • Ascensia, the Ascensia Diabetes Care logo and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.

ALCOR SCIENTIFIC PARTNERS WITH WATER STREET TO ACCELERATE EXPANSION

Retrieved on: 
Wednesday, February 23, 2022 - 12:02pm
Medtronic, Innovation, Erythrocyte sedimentation rate, Degenerative disease, Water Street, Growth, Inflammation, Investment, Family, Industry, Sale, Johnson & Johnson, Jim Post, PHC, Workflow, Walgreen, Thermo Fisher Scientific, Multimedia, ESR, Leadership, Cancer, Alere, Goal, History, CEO, Research, Infection, Health, Hospital, Medical imaging, Pharmaceutical industry, Management, Alcor, Humana

Alcor Scientific , a leading provider of diagnostic instrumentation and medical devices, announced today that it has partnered with strategic health care investor Water Street Healthcare Partners .

Key Points: 
  • Alcor Scientific , a leading provider of diagnostic instrumentation and medical devices, announced today that it has partnered with strategic health care investor Water Street Healthcare Partners .
  • Water Street has committed significant capital to invest in Alcor's expansion.
  • I'm very pleased to have found in Water Street a strategic partner that values our legacy and will help us build on it.
  • Alcor plans to leverage Water Street's investment to achieve its goals for accelerating the development of new technologies, expanding its product portfolio and bolstering its global reach.

Bradford White and PHCC extend exclusive strategic partnership agreement for 2022

Retrieved on: 
Tuesday, February 22, 2022 - 12:00pm
Workforce, Partnership, SkillsUSA, Growth, PCHP, Investment, Education, PHCC, Bradford White, Industry, Volunteering, Organization, Heat, PHC, Marketing, HVACR, White, Heating, ventilation, and air conditioning, Medicine

AMBLER, Pa., Feb. 22, 2022 /PRNewswire/ -- Bradford White Corporation , an industry-leading manufacturer of water heaters, boilers and storage tanks, and the Plumbing-Heating-Cooling ContractorsNational Association (PHCC) announce the renewal of their exclusive strategic partnership agreement and confirm their joint commitment to promoting and strengthening the plumbing and HVACR industries.

Key Points: 
  • AMBLER, Pa., Feb. 22, 2022 /PRNewswire/ -- Bradford White Corporation , an industry-leading manufacturer of water heaters, boilers and storage tanks, and the Plumbing-Heating-Cooling ContractorsNational Association (PHCC) announce the renewal of their exclusive strategic partnership agreement and confirm their joint commitment to promoting and strengthening the plumbing and HVACR industries.
  • "Our exclusive strategic partnership is based on the foundational values that drive Bradford White and PHCC," said Joel Long, president of PHCC.
  • Through its strategic partnership agreement with PHCC, Bradford White supports a range of scholarships, programs and initiatives dedicated to the advancement of contractor education and excellence, contractor business development, and promoting the value of the trades, including:
    The PHCC Educational Foundation, which provides innovative educational programming to enhance the growth and success of the plumbing and HVACR industry workforce.
  • PHCC Education Partner,in support of PHCC education and training that provides PHC business owners and their employees with easy access to high-quality education and training opportunities.

Preston Hollow Capital Completes Bond Purchase Relating to Miami-Dade County Infrastructure Project

Retrieved on: 
Friday, December 31, 2021 - 2:00pm
Construction & Property, Finance, Public Relations, Investor Relations, Public Policy, Government, Communications, Professional Services, Building Systems, State, Local, Other Construction & Property, Septic, Disclosure, Hope, The Bond Buyer, Goal, Solution, Partnership, Associate, PHC, S. Samuel DiFalco, PFM, Hook-up, Investment, Insurance, County

Dallas-based Preston Hollow Capital (PHC), an independent specialty municipal finance company that supports local communities through social impact financing, announced the completion of a $10.85 million purchase of special assessment revenue bonds relating to the Ojus Sanitary Sewer Special Benefit Area, located in Miami-Dade County, Florida.

Key Points: 
  • Dallas-based Preston Hollow Capital (PHC), an independent specialty municipal finance company that supports local communities through social impact financing, announced the completion of a $10.85 million purchase of special assessment revenue bonds relating to the Ojus Sanitary Sewer Special Benefit Area, located in Miami-Dade County, Florida.
  • The 30-year tax-exempt bonds were privately placed to Preston Hollow Capital by Drexel Hamilton, a veteran owned broker-dealer.
  • acted as bond counsel and Hunton Andrews Kurth LLP and DiFalco & Fernandez LLLP served as disclosure counsel.
  • Preston Hollow Capital provides specialized impact financing solutions for projects of significant social and economic importance to local communities in the United States.